Broadfin Capital’s Travere Therapeutics TVTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2019
Q4
Sell
-610,414
Closed -$7.08M 42
2019
Q3
$7.08M Sell
610,414
-442,900
-42% -$5.13M 1.31% 17
2019
Q2
$21.2M Buy
1,053,314
+37,200
+4% +$747K 4.6% 5
2019
Q1
$23M Hold
1,016,114
4.75% 6
2018
Q4
$23M Buy
1,016,114
+77,900
+8% +$1.76M 3.02% 5
2018
Q3
$27M Sell
938,214
-110,479
-11% -$3.17M 3.97% 5
2018
Q2
$28.6M Sell
1,048,693
-129,533
-11% -$3.53M 4.5% 6
2018
Q1
$26.3M Sell
1,178,226
-463,642
-28% -$10.4M 4.11% 7
2017
Q4
$34.6M Sell
1,641,868
-75,090
-4% -$1.58M 5.65% 4
2017
Q3
$42.7M Sell
1,716,958
-1,145,220
-40% -$28.5M 6.32% 3
2017
Q2
$55.5M Sell
2,862,178
-30,000
-1% -$582K 6.74% 2
2017
Q1
$53.4M Sell
2,892,178
-377,093
-12% -$6.96M 6.47% 3
2016
Q4
$61.9M Sell
3,269,271
-200,000
-6% -$3.79M 6.87% 3
2016
Q3
$77.6M Buy
3,469,271
+806,680
+30% +$18.1M 6.96% 2
2016
Q2
$47.4M Sell
2,662,591
-297,199
-10% -$5.29M 4.61% 4
2016
Q1
$40.4M Hold
2,959,790
3.9% 4
2015
Q4
$57.1M Buy
2,959,790
+350,000
+13% +$6.75M 3.51% 5
2015
Q3
$52.9M Buy
2,609,790
+446,862
+21% +$9.05M 2.94% 4
2015
Q2
$71.7M Sell
2,162,928
-799,370
-27% -$26.5M 3.85% 4
2015
Q1
$71M Buy
2,962,298
+303,444
+11% +$7.27M 5.53% 3
2014
Q4
$32.5M Buy
2,658,854
+100,000
+4% +$1.22M 2.83% 8
2014
Q3
$22.9M Buy
2,558,854
+883,603
+53% +$7.9M 2.4% 13
2014
Q2
$24.9M Buy
1,675,251
+65,555
+4% +$974K 2.43% 14
2014
Q1
$34.1M Buy
+1,609,696
New +$34.1M 3.31% 6